logo
Select company
Select metric
$ 44.92MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
49
Sector
81
Industry
93
History
100
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information

Ticker

STOK

Company Name

STOKE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

STOKE THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STOK - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 4.35M$ 40.57M$ 44.92M
3/31/2025$ 4.41M$ 38.45M$ 42.86M
12/31/2024$ 4.44M$ -101.62M$ -97.18M
9/30/2024$ 4.55M$ -117.71M$ -113.16M
6/30/2024$ 4.64M$ -114.93M$ -110.29M
3/31/2024$ 4.7M$ -118.76M$ -114.06M
12/31/2023$ 4.73M$ -114.61M$ -109.88M
9/30/2023$ 4.67M$ -112.2M$ -107.53M
6/30/2023$ 4.39M$ -112.11M$ -107.72M
3/31/2023$ 4.06M$ -104.08M$ -100.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -46.28M.
  • Over the past 5 years, STOKE THERAPEUTICS INC's average EBITDA has been $ -76.57M.
  • The median EBITDA for STOKE THERAPEUTICS INC during this period was $ -95.72M
  • STOKE THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 44.92M.
  • The lowest EBITDA recorded by STOKE THERAPEUTICS INC in the same timeframe $ -114.06M

STOKE THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
AKBA : AKEBIA THERAPEUTICS INC $ 15.38MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -86.04MDNA : GINKGO BIOWORKS HOLDINGS INC $ -222.12MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -101.19MGERN : GERON CORP $ -58.41MKROS : KEROS THERAPEUTICS INC $ 30.57MNAGE : NIAGEN BIOSCIENCE INC $ 19.78MCRMD : CORMEDIX INC $ 52.25MIOVA : IOVANCE BIOTHERAPEUTICS INC $ -343.89MPHAT : PHATHOM PHARMACEUTICALS INC $ -256.75M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for STOKE THERAPEUTICS INC is calculated as follows: EBIT [ $ -47.84M ] + DepAmor [ $ 1.56M ]
(=) EBITDA [ $ -46.28M ]

STOK - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -114.06M

Minimum

Mar 31, 2024

$ 44.92M

Maximum

Jun 30, 2025

$ -76.57M

Average

$ -95.72M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 166.93M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.76M
median$ 8.83M
std$ 166.93M